For the Inventor, By the Inventor

Enter assignee name

M2i Development

USPTO Granted Patents = 3

% Expired Patents = 66.7

EPO Patents = 2

Forward Citations = 2

Loading Chart...

Loading Chart...

5 inventors (with patents filed for the assignee):

Samuel Dufour (3 out of 10 patents)

Olivier Guerret (2 out of 73 patents)

Loic Guilloneau (1 out of 1 patent)

4. Hafid Belhadj-Tahar (1 out of 2 patents)

5. Valérie LeJeune (1 out of 1 patent)

6. Hubert Sevestre (1 out of 1 patent)

7. Philippe Reulet (1 patent)

8. Philippe Riviere (4 patents)

9. Daniel Guyot (1 patent)

10. Fabrice Leborgne (0 patent)

3 patents: Sort by Forward Citations

1. 9790171 - Synthesis intermediates for obtaining derivatives of sphingosines, ceramides and sphingomyelins with good yields (2017-10-17),

2. 9714212 - Chemical compounds derived from normemantine and use of same in the medical field (2017-07-25),

3. 9663531 - Process for the industrial synthesis of sordidin (2017-05-30),

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

3 Patents

#2 in Lacq

#4,030 in France

M2i Development

Forward Citations = 2

5 inventors:

Samuel Dufour (3 out of 10 patents)

Olivier Guerret (2 out of 73 patents)

Loic Guilloneau (1 out of 1 patent)

4. Hafid Belhadj-Tahar (1 out of 2 patents)

5. Valérie LeJeune (1 out of 1 patent)

Please report any incorrect information to [email protected]

Loading…